A pharmacokinetic study comparing the overnight switch effect from Immediate-Release Topiramate (TPM-IR) to Extended-Release Trokendi Xr™ (SPN-538) in adults with partial-onset or primary generalized seizures

Trial Profile

A pharmacokinetic study comparing the overnight switch effect from Immediate-Release Topiramate (TPM-IR) to Extended-Release Trokendi Xr™ (SPN-538) in adults with partial-onset or primary generalized seizures

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Topiramate (Primary) ; Topiramate (Primary)
  • Indications Generalised epilepsy; Partial epilepsies
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top